Langerhans cell histiocytosis presenting as a blueberry muffin rash
HTML: 5
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Langerhans cells, often referred to as the “macrophages of the skin”, are dendritic cells that normally reside in the epidermis and papillary dermis. Just like macrophages, they function as antigen-presenting cells that activate naive T cells. Certain mutations such as those involving the BRAF gene can cause unopposed production of Langerhans cells, which is known as Langerhans cell histiocytosis (LCH). LCH triggers an inflammatory immune response that causes systemic manifestations such as fever and fatigue, as well as other manifestations depending on the affected organs. The pathogenesis behind LCH remains poorly understood. It is still unknown whether it is a neoplastic process or a reactive cancer-mimicking illness. Diagnosis of LCH is confirmed by biopsy, and treatment is largely dependent on the extent and severity of the disease. Common treatments include corticosteroids, excision, radiation, and chemotherapy. We present a case of a 1- year-old Saudi male with LCH.
Tillotson CV, Anjum F, Patel BC. Langerhans Cell Histiocytosis. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430885 (cited on July 3rd, 2023)
McClain KL, Goyal G. Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis. UpToDate. Available from: https://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-langerhans-cell-histiocytosis?search=langerhans%20cell%20histiocytosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 (cited on July 3rd, 2023)
Herwig MC, Wojno TH, Zhang Q, Grossniklaus HE. Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature. Surv Ophthalmol 2013;58:330-40.
Ni M, Yang X. Langerhans’ cell histiocytosis of the temporal bone: a case report. Exp Ther Med 2017;13:1051-3.
Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. New Eng J Med 2018;379:856-68.
Guyot-Goubin A, Donadieu J, Barkaoui M, et al. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer 2008;51:71-5.
Aricò M, Girschikofsky M, Généreau T, et al. Langerhans cell histiocytosis in adultsReport from the International Registry of the Histiocyte Society. Eur J Cancer 2003;39:2341-8.
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.